BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.16% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.71% |
| 4 | Healthcare | 5.18% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCSB
3401
DELISTED
PCSB Financial Corporation
PCSB
| $42.3K | ﹤0.01% |
2,212
-3,369
| -60% | -$63.8K |
|
3402
Replimune Group
REPL
$1.4B
| $42.1K | ﹤0.01% |
2,481
-4,345
| -64% | -$82K |
|
|
RVI
3403
DELISTED
Retail Value Inc. Common Shares
RVI
| $41.9K | ﹤0.01% |
13,687
-20,083
| -59% | -$63.4K |
|
3404
Harvard Bioscience
HBIO
$30.3M
| $41.7K | ﹤0.01% |
672
-384
| -36% | -$22.7K |
|
3405
Rigel Pharmaceuticals
RIGL
$795M
| $41.7K | ﹤0.01% |
1,394
-2,060
| -60% | -$55.8K |
|
3406
IES Holdings
IESC
$15.1B
| $41.5K | ﹤0.01% |
1,033
-819
| -44% | -$36.9K |
|
3407
Atossa Therapeutics
ATOS
$25.9M
| $41.3K | ﹤0.01% |
2,204
-1,204
| -35% | -$24.5K |
|
3408
Old Second Bancorp
OSBC
$1.32B
| $41.2K | ﹤0.01% |
2,837
-10,001
| -78% | -$140K |
|
3409
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $41K | ﹤0.01% |
911
-72,807
| -99% | -$3.29M |
|
3410
Xenon Pharmaceuticals
XENE
$6.03B
| $40.8K | ﹤0.01% |
1,334
+1,254
| +1,568% | +$37.5K |
|
|
USX
3411
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $40.7K | ﹤0.01% |
10,499
-1,087
| -9% | -$4.87K |
|
|
ITIC
3412
Investors Title Co
ITIC
$543M
| $40.6K | ﹤0.01% |
200
-312
| -61% | -$62.2K |
|
3413
Establishment Labs
ESTA
$2.37B
| $40.6K | ﹤0.01% |
602
+584
| +3,244% | +$34.1K |
|
3414
Willis Lease Finance
WLFC
$1.2B
| $40.5K | ﹤0.01% |
3,777
-1,407
| -27% | -$16.3K |
|
3415
Ceco Environmental
CECO
$4.66B
| $40.5K | ﹤0.01% |
7,378
-5,956
| -45% | -$34.8K |
|
|
PRVB
3416
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $40.3K | ﹤0.01% |
5,512
-13,771
| -71% | -$82.4K |
|
|
FRGI
3417
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $40.3K | ﹤0.01% |
5,390
-6,811
| -56% | -$65.2K |
|
3418
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $39.9K | ﹤0.01% |
+1,577
| New | +$40.8K |
|
3419
HF Foods Group
HFFG
$99.2M
| $39.7K | ﹤0.01% |
5,964
-9,123
| -60% | -$63.1K |
|
3420
Donegal Group Class A
DGICA
$696M
| $39.2K | ﹤0.01% |
2,924
-3,479
| -54% | -$48.6K |
|
3421
iShares US Technology ETF
IYW
$25.6B
| $39.2K | ﹤0.01% |
380
-8,581
| -96% | -$876K |
|
|
PAMT
3422
PAMT Corp
PAMT
$267M
| $38.6K | ﹤0.01% |
1,111
-1,751
| -61% | -$62K |
|
|
DESP
3423
DELISTED
Despegar.com
DESP
| $38.3K | ﹤0.01% |
+3,136
| New | +$35.3K |
|
3424
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $37.8K | ﹤0.01% |
563
+104
| +23% | +$6.77K |
|
|
XOMA
3425
DELISTED
Xoma
XOMA
| $37.7K | ﹤0.01% |
1,347
-1,511
| -53% | -$34.5K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.